Bulletin
Investor Alert

Alexion Pharmaceuticals Inc.

NAS: ALXN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 3, 2021, 6:34 p.m.

/zigman2/quotes/206262068/composite

$

147.90

Change

-0.37 -0.20%

Volume

Volume 129,588

Quotes are delayed by 20 min

/zigman2/quotes/206262068/composite

Today's close

$ 150.37

$ 148.19

Change

-2.18 -1.45%

Day low

Day high

$148.14

$150.63

Open

52 week low

52 week high

$72.67

$162.60

Open

Brian M. Goff

Brian M. Goff is on the board of Pathways to College Network and Chief Commercial, Global Operations Officer & EVP at Alexion Pharmaceuticals, Inc.

He previously occupied the position of Chief Operating Officer & Director at Neurovance, Inc., Executive Vice President & President-Hematology at Baxalta, Inc., VP, Head-Primary Care & Established medicines at Novartis Pharmaceuticals Corp. and Head-Global Hemophilia Franchise at Baxter Healthcare Corp.

Brian M. Goff received an undergraduate degree from Skidmore College and an MBA from The Wharton School of the University of Pennsylvania.

Transactions

Date Shares Transaction Value
12/16/2020 3,261   Derivative/Non-derivative trans. at $157.96 per share. 515,108
12/16/2020 18,134   Derivative/Non-derivative trans. at $157.96 per share. 2,864,447
12/16/2020 40,677   Award at $0 per share. 0
06/08/2020 1,642   Derivative/Non-derivative trans. at $114.61 per share. 188,190
03/02/2020 1,401   Derivative/Non-derivative trans. at $90.54 per share. 126,847
02/28/2020 10,880   Award at $0 per share. 0
02/07/2020 1,594   Derivative/Non-derivative trans. at $102.97 per share. 164,135
06/07/2019 1,643   Derivative/Non-derivative trans. at $118.61 per share. 194,877
02/28/2019 9,428   Award at $0 per share. 0
02/28/2019 670   Derivative/Non-derivative trans. at $132.93 per share. 89,064
02/07/2019 1,596   Derivative/Non-derivative trans. at $119.57 per share. 190,834
06/08/2018 1,645   Disposition at $118.53 per share. 194,982
02/28/2018 8,940   Award at $0 per share. 0
02/08/2018 1,651   Disposition at $116.31 per share. 192,028
02/06/2018 15,894   Award at $0 per share. 0
06/07/2017 14,719   Award at $0 per share. 0

Officers and Executives

Dr. Ludwig N. Hantson
Chief Executive Officer & Director
Dr. Aradhana Sarin
Chief Financial Officer & Executive Vice President
Mr. Brian M. Goff
Chief Commercial, Global Operations Officer & EVP
Mr. George Llado
Chief Information Officer & Senior Vice President
Dr. John J. Orloff
Executive VP, Head-Research & Development
Dr. Tanisha V. Cariño
Chief Corporate Affairs Officer & EVP
Dr. Gianluca Pirozzi
Head-Clinical Development, Hematology & Nephrology
Mr. Uzair Qadeer
Chief Diversity Officer
Ms. Becky Lillie
Chief Human Experience Officer
Ms. Tamar Thompson
Vice President-US Government Affairs & Policy
Ms. Indrani M. Franchini
Chief Compliance Officer & Executive VP
Ms. Rana Strellis
SVP-Global Culture & Social Responsibility
Mr. Daniel A. Bazarko
Chief Accounting Officer & Senior Vice President
Mr. Christopher J. Stevo
Head-Investor Relations1
Ms. Morgan Sanford
Chief of Staff
Ms. Ellen V. Chiniara
Secretary, Chief Legal Officer & Executive VP
Mr. David Richard Brennan
Chairman
Dr. Andreas Rummelt
Independent Director
Mr. John T. Mollen
Independent Director
Mr. Christopher J. Coughlin
Independent Director
Dr. Paul A. Friedman
Independent Director
Dr. Francois Nader
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Ms. Judith A. Reinsdorf
Independent Director
Link to MarketWatch's Slice.